TriMas Co. (NASDAQ:TRS) Director Herbert K. Parker Buys 1,000 Shares

TriMas Co. (NASDAQ:TRS) Director Herbert K. Parker bought 1,000 shares of TriMas stock in a transaction on Wednesday, May 1st. The shares were purchased at an average cost of $25.98 per share, for a total transaction of $25,980.00. Following the acquisition, the director now owns 30,057 shares in the company, valued at $780,880.86. The purchase was disclosed in a filing with the SEC, which is available at the SEC website.

TriMas Trading Down 0.0 %

Shares of NASDAQ:TRS opened at $26.21 on Friday. TriMas Co. has a 1-year low of $22.59 and a 1-year high of $29.07. The company has a 50 day moving average price of $25.59 and a 200 day moving average price of $25.11. The stock has a market capitalization of $1.07 billion, a price-to-earnings ratio of 27.02 and a beta of 0.71. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.29 and a current ratio of 2.73.

TriMas (NASDAQ:TRS) last posted its quarterly earnings data on Tuesday, April 30th. The industrial products company reported $0.37 EPS for the quarter, beating analysts’ consensus estimates of $0.28 by $0.09. The company had revenue of $227.10 million during the quarter, compared to analyst estimates of $220.60 million. TriMas had a net margin of 4.48% and a return on equity of 9.68%. The business’s quarterly revenue was up 5.4% on a year-over-year basis. During the same period in the prior year, the firm earned $0.30 earnings per share. On average, research analysts anticipate that TriMas Co. will post 1.91 EPS for the current fiscal year.

TriMas Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, May 14th. Investors of record on Tuesday, May 7th will be issued a dividend of $0.04 per share. This represents a $0.16 annualized dividend and a dividend yield of 0.61%. The ex-dividend date is Monday, May 6th. TriMas’s dividend payout ratio is currently 16.49%.

Hedge Funds Weigh In On TriMas

A number of hedge funds have recently modified their holdings of TRS. Allspring Global Investments Holdings LLC raised its holdings in shares of TriMas by 16.0% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 3,069,777 shares of the industrial products company’s stock valued at $77,757,000 after purchasing an additional 422,717 shares in the last quarter. Norges Bank acquired a new position in TriMas during the 4th quarter valued at $6,767,000. Pzena Investment Management LLC raised its position in shares of TriMas by 7.0% during the third quarter. Pzena Investment Management LLC now owns 2,570,194 shares of the industrial products company’s stock valued at $63,638,000 after buying an additional 167,452 shares during the last quarter. Hillsdale Investment Management Inc. acquired a new stake in shares of TriMas during the 4th quarter worth approximately $3,764,000. Finally, Fiduciary Management Inc. WI lifted its holdings in TriMas by 4.3% during the 4th quarter. Fiduciary Management Inc. WI now owns 3,106,943 shares of the industrial products company’s stock valued at $78,699,000 after purchasing an additional 129,477 shares during the last quarter. 99.42% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, BWS Financial reissued a “buy” rating and set a $40.00 price target on shares of TriMas in a research report on Wednesday.

About TriMas

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.